CanSino Biologics, Inc. Class H's total assets for Q2 2024 were ¥8.13B, a decrease of -5.07% from the previous quarter. HK:6185 total liabilities were ¥3.08B for the fiscal quarter, a -11.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.